"Rescue" Abciximab for complicated percutaneous transluminal coronary angioplasty

American Journal of Cardiology

Volumn 82, Issue 6 A, 1998, Pages 800-803

  Garbarz, Eric ^a   Farah, Bruno ^b   Vuillemenot, Alain ^b   André, Francis ^b   Angioí, Michaél ^b   Machecourt, Jacques ^b   Bassand, Jean Pierre ^b   Wolf, Jean Eric ^b   Danchin, Nicolas ^b   Prendergast, Bernard ^b   Lung, Bernard ^b   Vahanian, Alec ^b  

^a HÔPITAL TENON   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; HEPARIN; NITRIC ACID DERIVATIVE; TICLOPIDINE; VERAPAMIL;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANTICOAGULANT THERAPY; AORTA BALLOON; ARTICLE; BLEEDING; CORONARY ARTERY THROMBOSIS; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SAFETY; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0032530191     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9149(98)00459-7     Document Type: Article

References (16)

1. Landau C, Lange RA, Hillis LD. Percutaneous transluminal coronary angioplasty. N Engl J Med 1994;330:981-993.
2. Gasperetti CM, Gognias SL, Gimple L, Powers ER. Platelet activation during coronary angioplasty in humans. Circulation 1993;88:2728-2734.
3. Coller BS. Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy. Circulation 1995;92:2373-2380.
4. The EPIC Investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
5. The CAPTURE Investigators. Randomised placebo-controlled trial of Abciximab before and during coronary intervention in refractory unstable angina : the CAPTURE study. Lancet 1997;349:1429-1435.
6. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-1696.
7. Gold HK , Garabedian HK, Dinsmore RE, Guerrero LJ, Cigarroa JE, Palacios IF, Leinbach RC . Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody whitout exogenous plasminogen activators. Circulation 1997;95:1755-1759.
8. Muhlestein JB, Gomez MA, Karagounis LA, Andersen JL. "Rescue Reopro": acute utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty (abstr). Circulation 1995;92(suppl I):I-607.
9. Brener JJ, Deluca SA, Rouse LC, Juran NB, Brezina KJ, Ellis SG. Planned versus "rescue" abciximab during angioplasty: in-hospital outcomes (abstr). Circulation 1996;94(suppl I):1-375.
10. Makkar RR, Litvack F, Eigler NL, Nakamura M, Ivey PA, Forrester JS, Shah PK, Jordan RE, Kaul S. Effects of GPIIbIIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis. Circulation 1997;95:1015-1021.
11. Maimaitiming A, Rupprecht HJ. Comparison of Reopro vs intracoronary thrombolysis for acute coronary stent thrombosis (abstr). Circulation 1997; 96(suppl I):96:I-640.
12. Henry P, Boughalem K, Rinaldi JP, Makowski S, Khalife K, Guermonprez JL, Blanchard D. Use of anti-GP IIb-IIIa in acute thrombosis after intracoronary stent implantation. Cathet Cardiovasc Diagn 1998;43:105-107.
13. Lincoff AM. Heparin and control of bleeding complications during platelet glycoprotein IIb/IIIa receptor antagonist therapy during percutaneous coronary revascularization. J Invas Cardiol 1996;8(suppl B):15-19.
14. 3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. J Am Coll Cardiol 1997;30:149-156.
15. Lefkovits J, Ivanhoe RJ, Califf RM, Bergelson BA, Anderson KM, Stoner GL, Weisman HF, Topol EJ. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996;77:1045-1051.
16. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997;336:1621-1628.